At its meeting on September 10, 2024, Beacon Angels conducted the following business:

We entertained new funding presentations as follows:

• FreezeNit, a patent-pending technology that kills head lice and nits using only cold CO2 gas without the need for harmful pesticides, or messy prescriptions; and
• AiM Medical Robotics, a neurosurgical robotics company commercializing a unique compact MRI-compatible surgical robot for brain surgery.

Beacon portfolio update:

• Pykus Therapeutics, developing a better means to secure the retina following reattachment surgery.

Report on companies in due diligence:

• ClearCut Surgical, developing electrocautery surgeons’ tools that incorporate smoke evacuation, fluid suction, and blunt dissection.
• WAHTS Hearing.

Report on pending funding rounds by Series number.

• 129 QSM Diagnostics, delivering rapid diagnostic test kits and devices to pet owners and veterinarians.
• 130 Surgicure, a medical device company that is innovating airway management for civilian and military use; and
• 131 Pykus.